![](/img/cover-not-exists.png)
Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial
Stirban, A. O., Andjelkovic, M., Heise, T., Nosek, L., Fischer, A., Gastaldelli, A., Herz, M.Volume:
18
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12620
Date:
July, 2016
File:
PDF, 128 KB
english, 2016